[{"NetIncomeLoss_1_Q3_USD":-87336000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":58074000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":20249000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":43778607.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":44614226.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":10457000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-80517000.0,"Depreciation_3_Q3_USD":435000.0,"Depreciation_1_Q3_USD":200000.0,"StockIssuedDuringPeriodValueNewIssues_3_Q3_USD":323977000.0,"MarketableSecuritiesCurrent_0_Q3_USD":447616000.0,"PaymentsToAcquireInvestments_3_Q3_USD":456608000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":66670000.0,"AssetsCurrent_0_Q3_USD":595391000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":11714087.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":11508786.0,"CommonStockSharesIssued_0_Q3_shares":44482308.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":447616000.0,"Assets_0_Q3_USD":619851000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":-24000.0,"ShareBasedCompensation_3_Q3_USD":64104000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":600000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":3000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":568000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":216644000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":79853000.0,"PrepaidExpenseCurrent_0_Q3_USD":8892000.0,"AssetsFairValueDisclosure_0_Q3_USD":590450000.0,"ProceedsFromStockPlans_3_Q3_USD":524000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":6178000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":1342000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_3_Q3_USD":877000.0,"CommonStockValue_0_Q3_USD":45000.0,"Revenues_3_Q3_USD":11690000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-827000.0,"Revenues_1_Q3_USD":11424000.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":6985000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":360825000.0,"RestrictedCash_0_Q3_USD":620000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-256282000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-88163000.0,"OtherAssetsNoncurrent_0_Q3_USD":7159000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":131434000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":378952000.0,"Liabilities_0_Q3_USD":68908000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":36283000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":17306000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":323977000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"InterestReceivableCurrent_0_Q3_USD":1535000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1464000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":940000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":64104000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":21751000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-195110000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_3_Q3_USD":36284000.0,"StockIssuedDuringPeriodValueEmployeeBenefitPlan_1_Q3_USD":12351000.0,"LiabilitiesCurrent_0_Q3_USD":67367000.0,"AccountsPayableCurrent_0_Q3_USD":15975000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":132054000.0,"InvestmentsFairValueDisclosure_0_Q3_USD":447616000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":16341000.0,"ProceedsFromStockOptionsExercised_1_Q3_USD":12400000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":131434000.0,"AdditionalPaidInCapital_0_Q3_USD":1569592000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":1092468.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q3_shares":272158.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_3_Q3_USD":524000.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":5901000.0,"NetIncomeLoss_3_Q3_USD":-256850000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":36300000.0,"RestrictedCashNoncurrent_0_Q3_USD":600000.0,"CommonStockSharesOutstanding_0_Q3_shares":44482308.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":85198000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"OperatingIncomeLoss_3_Q3_USD":-263028000.0,"OperatingIncomeLoss_1_Q3_USD":-88678000.0,"PreferredStockValue_0_Q3_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":619851000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":8000000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":64104000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":21751000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":7365000.0,"OperatingExpenses_3_Q3_USD":274718000.0,"OperatingExpenses_1_Q3_USD":100102000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-5.87,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.96,"OtherLiabilitiesNoncurrent_0_Q3_USD":1541000.0,"StockholdersEquity_0_Q3_USD":550943000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2861000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":446679000.0,"LongTermInvestments_0_Q3_USD":11400000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":11690000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":11424000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1029151000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":843000.0,"ClassOfWarrantOrRightOutstanding_0_Q3_shares":9092873.0,"Ticker":"MRTX","CIK":"1576263","name":"MIRATI THERAPEUTICS, INC.","OfficialName":"Mirati Therapeutics Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"4261498445.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201104"}]